Affiliations 

  • 1 The George Institute for Global Health, School of Medicine, University of Sydney, New South Wales, Australia
  • 2 GlaxoSmithKline, Global Epidemiology, Middlesex, United Kingdom
  • 3 Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology Baltimore, USA
  • 4 Okinawa Heart and Renal Association (OHRA) and Clinical Research Support Center, Tomishiro Central Hospital, Okinawa, Japan
  • 5 Sultanah Aminah Hospital, Haemodialysis Unit, Johor Bahru, Malaysia
  • 6 The George Institute for Global Health, India, New Delhi, India
Nephrology (Carlton), 2017 Jun;22(6):456-462.
PMID: 27187157 DOI: 10.1111/nep.12821

Abstract

AIM: The burden of chronic kidney disease (CKD) is growing rapidly around the world. However, there is limited information on the overall regional prevalence of CKD, as well as the prognostic implications and treatment patterns in Asian region. We have established the Asian Renal Collaboration (ARC) with the goal of consolidating region-wide data regarding CKD.

METHODS: This collaborative project will synthesize data and perform meta-analyses of observational studies conducted in Asia. Studies will be identified through a systematic literature search including abstracts, proceedings of meetings, electronic databases such as MEDLINE and EMBASE. Personal enquiry among collaborators and experts in the region will identify additional studies, or other data sources such as registries. Both cross-sectional and longitudinal studies that describe the prevalence of CKD and its complications will be included, as will longitudinal studies that describe important clinical outcomes for people with CKD. Individual participant data will be sought, where possible, from each of the studies included in the collaboration for baseline parameters and subsequent outcomes, in order to maximize flexibility and consistency of data analyses.

CONCLUSIONS: This study is an initiative offering a unique opportunity to obtain information about the prevalence and manifestations of CKD in Asia, as well as its risk factors. The ARC will also provide insights into important outcomes including progression of CKD, CKD complications, cardiovascular disease and death. These findings will improve our understanding of kidney disease in Asia, and thus help inform service provision, preventive care and further research across the region.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.